Location
Please check the individual session for location or broadcast availability.
Frequency
Weekly
Series Director
Jacob Mandel, MD
Target Audience
Needs Statement
Learners require targeted education that increases their knowledge of current evidence-based guidelines and enhances their competence in applying new diagnostic and therapeutic approaches to neurological diseases. Subspecialist-led sessions on neurological testing and disease management can help participants understand the latest advances in migraine pharmacology, acute and preventive stroke strategies, and the integration of comorbidity management into neurological care. The educational activities of this series will focus on translating guideline recommendations into clinical decision-making, improving the ability to assess and manage patients using up-to-date techniques, and fostering the implementation of a wide spectrum of therapeutic interventions based on the latest evidence.
Educational Methods
Educational methods will include lectures and case presentations.
Objectives
At the conclusion of the sessions, the participants should be able to:
- Analyze recent scientific advances across neurological disorders and apply current assessment techniques to improve diagnostic accuracy and clinical decision-making.
- Evaluate the utility of novel therapeutic interventions for patients with neurologic disease, including new pharmacological agents and preventive strategies.
- Implement a wide spectrum of therapeutic interventions for patients with neurological disease, guided by the latest evidence-based knowledge and clinical practice guidelines.
Evaluation
Participants may be asked to complete a session evaluation.
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Facebook
X
LinkedIn
Forward